New blog posts
Bioprocessing Analytics Equipment Market will reach at a CAGR of 4.5% from 2018 - 2028
by Guest on Aug 6, 2018
Future Market Insights (FMI) delivers key insights on the global bioprocessing analytics equipment market in an upcoming report titled “Bioprocessing Analytics Equipment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global bioprocessing analytics equipment market is anticipated to register a CAGR of 4.5% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.
Request For TOC @https://www.futuremarketinsights.com/askus/rep-gb-5405
Bioprocessing Analytics Equipment Market: Segmental Analysis
The global bioprocessing analytics equipment market is segmented based on product type, application, end user and region. Based on product type the market is segmented into osmometers and bioprocess analysers. Osmometers is the leading product type in the bioprocessing analytics equipment market over the forecast period. North America is expected to gain popularity over the forecast period, driven by cell-based bioprocesses extensively utilised for therapeutics protein production. Manual monitoring of such bioprocesses is labour intensive and can lead to errors in the production process. Due to rapid advancements in technology, manufacturers have developed integrated multi-functional analysers, which combine the functionality of different single analyzers (like cell counters, osmometers, nutrient/electrolyte/metabolite bio-profile analyzers) into one technologically enabled novel sampling system to analyse the culture medium automatically. The integration of multiple functionality allows feedback control of parameters and reduces error rates in bioprocessing.
Request For Sample @https://www.futuremarketinsights.com/reports/sample/rep-gb-5405
The market is further categorised based on application into clinical and industrial applications. The industrial application segment is expected to lead in the global bioprocessing analytics equipment market during the assessment period. Demand for bioprocessing analytics equipment is anticipated to be the highest across various industries, and the industrial segment is projected to register a CAGR of 4.4% over the forecast period.
The market is further classified based on end users. End user segments include Biopharmaceutical Companies, Contract Research Organization (CROs), Contract Manufacturing Organizations (CMOs), Academics & Research Institutes, and Clinical Diagnosis. Biopharmaceutical companies are the largest end users of bioprocessing analytics equipment while demand for bioprocessing analytics equipment is expected to be the highest in Biopharma companies – anticipated to register a growth rate of 3.9% over the forecast period.
Bioprocessing Analytics Equipment Market: Regional Forecast
This report assesses trends that are driving the growth of each market segment at the global as well as regional level, and offers potential takeaways that could prove substantially useful to manufacturers looking to enter the market. The North America market is estimated to dominate the global bioprocessing analytics equipment market, accounting for a maximum revenue share of the market by 2018 end. The Western Europe and APECJ markets are collectively expected to account for around 39.2% of the total bioprocessing analytics equipment market share in terms of value by 2018 end. Revenue from the market in APECJ is projected to expand at a CAGR of 5.9% over the forecast period.
Most Recent Articles
- Aug 8, 2018 Contrast Media Injectors Market will Exhibit a Steady 5.6% CAGR through 2015-2025 by Guest
- Aug 8, 2018 Branded Generics Market Market CAGR Projected to Grow at 7.3% through 2016-2026 by Guest
- Aug 8, 2018 General Anesthesia Drugs market to expand at a CAGR of 3.8% by 2025 by Guest
- Aug 8, 2018 Bone Growth Stimulators Market will reach at a CAGR of 9.5% from 2015-2025 by Guest
- Aug 8, 2018 Neonatal Thermoregulation Market to Grow at a CAGR of 5.0% through 2027 by Guest